NCT04036097Completed
Prospective Stratification of Infectious Risks in Multiple Sclerosis
Prospective Stratification of Infectious Risks in Multiple Sclerosis (InRIMS-Study)
Source: ClinicalTrials.gov · Last updated 17 Apr 2025
Brief summary (registry, in English)
This monocentric study is to identify factors that increase the susceptibility for infections and establish a questionnaire-based infection score that allows a prospective stratification for infectious risks in patients with multiple sclerosis (MS) (InRIMS-Study). The study will utilize a validated, MS-adapted questionnaire and infection diary from the Airway Infection Susceptibility (AWIS) study in a regularly followed, prospective cohort of MS patients. It is a nested project of the prospective observational Swiss MS Cohort (SMSC) and SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 298 (actual)
- First submitted
- 25 Jul 2019
- Start date
- 10 Apr 2019
- Primary completion date
- 31 Dec 2022
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Multiple sclerosis
- NCT number
- NCT04036097
What you commit to
- Study type: Observational
- Participants enrolled: 298
- From 10 Apr 2019 to the primary completion date, 31 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- MS Patients with known primary immunodeficiency, under chemotherapy due to any malignancy or HIV infection.
Other
- Not able to sufficiently understand the patient information and questionnaire (German language)
- MS Patients with long-term antibiotic prophylaxis
Who the study is looking for
- Signed informed consent form (ICF) for the InRIMS-study and Swiss MS Cohort (SMSC) and/or Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT) study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Basel, Department of Neurology Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.